Updated overall survival (OS) results for BRF113220, a phase I-II study of dabrafenib alone versus combined dabrafenib and trametinib in patients with BRAF V600 metastatic melanoma (MM)

Adil Daud, Jeffrey S. Weber, Jeffrey Alan Sosman, Kevin Kim, Rene Gonzalez, Omid Hamid, Jeffrey R. Infante, Jonathan S. Cebon, Lynn Mara Schuchter, Georgina V. Long, Alain Patrick Algazi, Ragini Reiney Kudchadkar, Igor Puzanov, Donald P. Lawrence, Richard Kefford, Amy S. Kline, Heather Lynn Del Buono, Peng Sun, Diane Opatt McDowell, Keith Flaherty

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)9036
Number of pages1
JournalJournal of Clinical Oncology
Issue number15 supplement
Publication statusPublished - 20 May 2015
Externally publishedYes
EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
Duration: 31 May 20134 Jun 2013

Cite this